Despite Aveanna Healthcare's recent rally, its P/S ratio remains low amid predictions its growth will lag industry standards. This suggests investor expectation of limited future growth and a reluctance to pay more for its current state, likely averting a substantial price rise soon.
Despite steady returns on capital employed, Aveanna Healthcare Holdings is not displaying potential for high growth. Market optimism should be tempered in light of current underlying trends.
Aveanna Healthcare股票討論區
Can’t buy this at moomoo?
Loaded
專欄Top upgrades and downgrades on 7/5: SHOP, HPQ, CROX, NTES and more
• $Antero Resources(AR.US)$ : Truist Securities Upgrades to Buy from Hold - PT $50 (from $42)
• $Coinbase(COIN.US)$ : US Tiger Securities Upgrades to Hold from Sell - PT $50
• $卡駱馳(CROX.US)$ : Loop Capital Upgrades to Buy from Hold - PT $75
• $Excelerate Energy(EE.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $29
• $德州儀器(TXN.US)$ : DZ Bank Upgrades to Hold from Buy - PT $150
Downgrades
• $Aveanna Healthcare(AVAH.US)$ : Truist ...
專欄Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $反導工業(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $美國電塔(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $丘奇&德懷特(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $康西哥(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
暫無評論